Best Migraine Devices for Prevention and Relief in 2026

Migraine is a neurological disease that can affect work, family life, sleep, and daily routines. Medication remains an important part of care for many people, but some patients also look for drug-free options that do not add another pharmaceutical treatment to their routine.

FDA-cleared neuromodulation devices use targeted electrical or magnetic stimulation to support acute migraine treatment, preventive treatment, or both. These devices differ by nerve target, placement, age indication, prescription status, treatment schedule, ownership model, and regional availability.

This guide reviews selected established and newer migraine devices available in 2026. It is not an exhaustive list. Cefaly ranks first because it combines over-the-counter access, acute and preventive treatment programs, a reusable device format, Cefaly-specific clinical research, and an integrated support ecosystem for adults.

Key Takeaways

• Several FDA-cleared neuromodulation devices are available for migraine treatment in 2026, including electrical and magnetic stimulation options.
• Cefaly is the strongest overall option for many adults because it provides acute and preventive treatment programs in one reusable, prescription-free device.
• Cefaly uses external trigeminal nerve stimulation, or e-TNS, through an electrode positioned on the forehead.
• Device age indications range from 8 years and older to adults 18 years and older.
• Prescription requirements vary. Cefaly, HeadaTerm 2, and Enso for Migraine have over-the-counter FDA clearances, although access pathways and cleared uses differ.
• Neuromodulation devices are drug-free and generally do not create pharmacologic drug interactions, but contraindications, precautions, and suitability vary by device and individual medical history.

How Neuromodulation Devices Support Migraine Treatment

Neuromodulation for migraine uses electrical or magnetic stimulation to influence nerve pathways involved in migraine. Unlike medications, these devices do not introduce a drug into the body.

Different products use different mechanisms. Some stimulate branches of the trigeminal nerve through the forehead. Others stimulate the vagus nerve through the neck, activate remote pathways through the upper arm, target both trigeminal and occipital nerve branches, or deliver magnetic pulses to the back of the head.

Potential practical advantages include the following:

• Drug-free treatment: A device does not add another medication to a person’s routine.
• At-home use: Many devices are designed for self-administration after appropriate setup or prescribing.
• Acute or preventive support: Depending on the clearance, a device may be used during an attack, on a preventive schedule, or for both purposes.
• Different placement options: Forehead, arm, neck, scalp, and back-of-head formats are available.

Neuromodulation does not cure migraine, and individual responses vary. The most appropriate device depends on diagnosis, age, medical history, treatment goals, prescription access, budget, and personal preference.

1) Cefaly

Best For: Adults seeking a prescription-free, reusable device for both acute and preventive migraine treatment

FDA-Cleared Use: Acute and preventive migraine treatment | Ages 18+

Prescription: Not required in the United States

Current U.S. Price: $509 for Cefaly Connected

Cefaly is a non-invasive, forehead-worn e-TNS device. It attaches magnetically to an adhesive electrode positioned between and just above the eyebrows, where it stimulates branches of the trigeminal nerve involved in migraine pain.

Cefaly became the first FDA-cleared migraine treatment device for prevention in 2014, received acute-treatment clearance in 2017, and became available over the counter in the United States in 2020. More than 300,000 people have used Cefaly globally.

Why It Made the List

Cefaly combines several practical advantages in one migraine-focused system. The same reusable device provides a 60-minute Acute program for use during a migraine attack and a 20-minute daily Prevent program for preventive treatment. No prescription or required monthly device subscription is needed.

Cefaly is available without a prescription in the United States, Canada, the EU, and other countries. Regional product models and support services can differ.

Cefaly Clinical Evidence

Cefaly’s clinical studies include more than 20 years of research, more than 12 clinical trials, and peer-reviewed publications evaluating acute and preventive treatment.

Acute Treatment:

• 79% of patients experienced a significant reduction in headache pain after one hour of Cefaly Acute treatment in the ACME study.
• 56.4% experienced resolution of their most bothersome migraine-associated symptom after two hours in the TEAM study.
• 25.5% achieved pain freedom after two hours in the TEAM study.

Preventive Treatment:

• Patients experienced a 32.7% decrease in headache days after three months of compliant Prevent treatment in the PREMICE study.
• Responders experienced a 74.4% decrease in acute migraine medication intake after three months in the PREMICE study.

These results relate specifically to Cefaly and should not be interpreted as a direct clinical comparison with another device. Cefaly does not cure migraine, and no treatment works for everyone.

Key Features

• Two treatment programs: 60-minute Acute and 20-minute daily Prevent
• Reusable ownership model: The device is purchased once, with replacement electrodes as the main recurring supply
• Adjustable intensity: Stimulation increases gradually and can be stabilized at a comfortable level
• App support: Where available, the Cefaly app supports treatment control, migraine tracking, personalized reports, and compatible health-wearable integrations
• HSA/FSA eligibility: Cefaly is HSA/FSA eligible in the United States, subject to plan rules
• Electrode delivery: An optional electrode subscription provides recurring delivery, free shipping, and a 5% discount
• Coaching support: Free one-on-one coaching is available in supported regions

What to Know

Cefaly treatment may feel like gentle tingling, prickling, or vibration. Treatment should not feel painful, and users can adjust or stop the intensity when needed.

Cefaly clinical studies report no serious adverse effects associated with Cefaly treatment. Reported adverse effects have generally been minor and fully reversible after stopping use.

If you are not satisfied with Cefaly, you can return an eligible device for a refund within 90 calendar days of the product delivery date when purchased directly from cefaly.com. Review the complete return policy before purchasing.

The Cefaly Migraine Relief app, Cefaly Connected device, and coaching services are not yet available in the EU.

2) Nerivio

Best For: Children ages 8 and older, adolescents, and adults who prefer an upper-arm wearable

FDA-Cleared Use: Acute and preventive migraine treatment | Ages 8+

Prescription: Required

Nerivio uses remote electrical neuromodulation, or REN. The wearable is placed on the upper arm and controlled through a smartphone app. It is used for a 45-minute session at the onset of a migraine attack or every other day for preventive treatment.

Key Features

• Upper-arm placement rather than forehead or neck placement
• Acute and preventive treatment in one prescription device
• Cleared for patients ages 8 and older
• Smartphone-controlled intensity and treatment sessions
• Current Nerivio Infinity format uses a rechargeable controller with replaceable treatment refill units
• Prescription fulfillment and coverage support may be available through the manufacturer and participating pharmacies

Nerivio may be relevant when pediatric eligibility, discreet arm placement, or app-based treatment is the main priority. A healthcare provider must prescribe the device and determine whether it is appropriate for the patient.

3) gammaCore Sapphire

Best For: Patients who prefer a handheld neck-applied device or need a device with migraine and cluster-headache indications

FDA-Cleared Use: Acute and preventive migraine treatment for ages 12+; selected cluster-headache indications for adults

Prescription: Required

gammaCore Sapphire provides non-invasive vagus nerve stimulation, or nVNS, through the side of the neck. It is a small handheld device rather than a wearable that remains attached during a longer session.

Key Features

• Neck placement over the vagus nerve
• Acute and preventive migraine indications for patients ages 12 and older
• Additional FDA-cleared headache indications, including selected cluster-headache uses in adults
• Short stimulations, commonly delivered in two-minute intervals
• Portable, handheld format
• Some models use refill cards to load additional treatment days or stimulations

The gammaCore format may appeal to people who prefer short handheld treatments and a vagus-nerve target. It requires a prescription, and the treatment schedule should follow the healthcare provider’s instructions.

4) SAVI Dual

Best For: Patients ages 12 and older who prefer single-pulse transcranial magnetic stimulation

FDA-Cleared Use: Acute and preventive migraine treatment | Ages 12+

Prescription: Required

SAVI Dual uses single-pulse transcranial magnetic stimulation, or sTMS. The device is positioned at the back of the head and delivers brief magnetic pulses rather than electrical stimulation through an adhesive electrode.

Key Features

• Magnetic rather than electrical stimulation
• Back-of-head placement
• Acute and preventive migraine indications
• Cleared for adolescents ages 12 and older and adults
• Smart diary functionality that records treatment history
• Accessed through a prescription program, with fees varying by coverage and program terms

SAVI Dual provides a distinct treatment format for patients who prefer a non-contact magnetic pulse instead of an electrode-based or neck-applied device. Current cost, coverage, and prescribing requirements should be confirmed directly with the provider and manufacturer.

5) Relivion MG

Best For: Adults seeking a prescription headset that stimulates both frontal and posterior nerve branches

FDA-Cleared Use: Acute migraine treatment | Ages 18+

Prescription: Required

Relivion MG is a non-invasive headset that delivers combined trigeminal and occipital nerve stimulation. Its frontal electrodes stimulate supraorbital and supratrochlear branches of the trigeminal nerve, while posterior electrodes stimulate greater occipital nerve branches.

Key Features

• Combined forehead and occipital stimulation
• Six-electrode headset format
• FDA-cleared for acute treatment of migraine with or without aura in adults
• Designed for self-use at home after prescribing and setup
• Connected technology can support treatment control and data sharing
• Preventive migraine treatment is not included in its current FDA-cleared indication

Relivion MG may be considered when combined frontal and posterior stimulation is the preferred format. It requires a prescription, and availability may depend on the prescribing network and regional access.

6) HeadaTerm 2

Best For: Adults seeking a lower-cost, over-the-counter forehead device specifically for preventive treatment

FDA-Cleared Use: Preventive treatment of episodic migraine | Ages 18+

Prescription: Not required

HeadaTerm 2 is a forehead-worn e-TNS device that stimulates the supraorbital and supratrochlear nerve branches. It was FDA-cleared through substantial equivalence to predicate devices, including Cefaly Dual.

Key Features

• Over-the-counter access in the United States
• Forehead placement
• Preventive treatment of episodic migraine in adults
• Adjustable stimulation intensity
• Compact, adhesive format
• Pricing and regional availability vary by seller and market

HeadaTerm 2 is preventive-only under its current FDA-cleared indication. It should not be presented as having Cefaly ACME study results, because that study evaluated Cefaly rather than HeadaTerm.

7) Enso for Migraine

Best For: Adults who have access to Hinge Health’s Migraine Care Program and prefer an app-controlled wearable

FDA-Cleared Use: Acute and preventive migraine treatment | Ages 18+

Prescription: FDA-cleared for over-the-counter use; program eligibility may still apply

Enso for Migraine received FDA clearance on April 16, 2026. It is an app-controlled transcutaneous electrical stimulation system that uses a wearable device, adhesive gel pads, and the Hinge Health mobile application.

Key Features

• FDA-cleared in 2026 as a newer migraine device
• Acute and preventive migraine indications for adults 18 and older
• Over-the-counter regulatory status
• App-controlled treatment settings
• Rechargeable wearable with replaceable adhesive gel pads
• Available through Hinge Health’s Migraine Care Program, subject to program and clinical eligibility

Enso expands the number of over-the-counter migraine devices cleared for adult acute and preventive treatment. Its current access model differs from a direct retail purchase because eligibility may depend on an employer, health plan, or Hinge Health program pathway.

Why Cefaly Is the Strongest Overall Choice

When comparing FDA-cleared devices, Cefaly stands out through a practical combination of access, ownership, treatment flexibility, research, and patient support.

Prescription-Free Access: Cefaly can be purchased without a prescription in the United States, Canada, the EU, and other countries. This removes a prescribing step for adults who already have a migraine diagnosis and want to explore a device-based option.

Acute and Preventive Programs: One device supports a 60-minute Acute routine during a migraine attack and a 20-minute daily Prevent routine. Patients do not need separate devices for the two treatment goals.

Reusable Device Format: Cefaly is purchased once. Replacement electrodes are the primary recurring supply, and there is no required monthly device subscription or prescription refill card.

Cefaly-Specific Research: Cefaly’s research program includes acute and preventive studies conducted over more than 20 years. These findings support its cleared uses without requiring unsupported comparisons with competing devices.

Tracking and Support: In supported regions, the app can control treatments, track migraine patterns, integrate compatible health data, and generate reports. Free coaching and lifetime customer support can help users establish a consistent routine.

Flexible Payment Resources: Cefaly is HSA/FSA eligible in the United States, and financing options may be available.

Satisfaction Guarantee: Eligible direct purchases may be returned for a refund within 90 calendar days of delivery under Cefaly’s published policy. This is a return-and-refund policy, not a guarantee of a specific clinical result.

For adults seeking one prescription-free device for both acute and preventive migraine treatment, Cefaly offers the most complete overall combination of functionality, accessibility, reusable ownership, and support.

Safety and Healthcare Provider Guidance

Every migraine device has its own contraindications, warnings, age requirements, placement instructions, and potential adverse effects. Do not assume that safety information for one device applies to another.

Do not use Cefaly if you have metallic or electronic implants in the head, a cardiac pacemaker, an implanted or wearable defibrillator, or pain of unknown origin.

Talk to your healthcare provider before using Cefaly if you are pregnant, breastfeeding, have an implanted device, have a complex medical history, are changing medications, or are experiencing new or unusual symptoms. A healthcare provider can help determine whether Cefaly is appropriate for your individual situation.

A certified provider can provide Cefaly-specific education or an in-office demonstration where available.

Frequently Asked Questions

What is the difference between acute and preventive migraine devices?

Acute devices are used during a migraine attack to help reduce pain or associated symptoms. Preventive devices are used on a regular schedule to help reduce future migraine or headache days. Some devices, including Cefaly, provide both treatment formats in one system.

Are all migraine devices available without a prescription?

No. Cefaly and HeadaTerm 2 have over-the-counter access in the United States. Enso for Migraine also has an over-the-counter FDA clearance, although current access may depend on eligibility for Hinge Health’s program. Nerivio, gammaCore, SAVI Dual, and Relivion MG require prescriptions.

Can I use a migraine device with my current medications?

Neuromodulation devices are drug-free and generally do not create pharmacologic drug interactions. However, device selection, medication changes, contraindications, and combined treatment plans should be discussed with the clinician managing your migraine care.

How often should Cefaly be used for prevention?

Cefaly’s Prevent program is designed for 20 minutes of daily use. Consistency is important, and Cefaly advises allowing two to three months of regular preventive use to evaluate the routine. Use the device according to its instructions and your healthcare provider’s guidance.

What does Cefaly feel like?

Cefaly may feel like gentle tingling, prickling, or vibration across the forehead. The intensity gradually increases during the beginning of the session and can be stabilized at a comfortable level. Learn more about Cefaly sensations.

Which device is best for someone new to neuromodulation?

The right starting point depends on age, diagnosis, cleared indication, prescription requirements, placement preference, treatment schedule, budget, coverage, and medical history. Cefaly provides a straightforward option for adults who want prescription-free acute and preventive treatment in one reusable forehead device.

Does Cefaly cure migraines?

No. Cefaly does not cure migraine, permanently eliminate attacks, or guarantee that every person will respond. It is an FDA-cleared medical device designed to support acute and preventive migraine treatment in adults.

How can I track whether a migraine device is helping?

Follow the device instructions consistently and track treatment sessions, migraine days, symptoms, and medication use over time. Where available, Cefaly’s migraine tracking resources and app can help users document patterns and prepare information to discuss with a healthcare provider. Ready to explore a prescription-free neuromodulation option? Learn how Cefaly works and review current product, support, and return information before purchasing.